Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
CC transcript
|
|
PALISADE BIO, INC. (CUR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 10% stake in PALISADE BIO, INC. |
| 08/22/2022 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Palisade Bio, Inc. |
| 08/18/2022 |
SC 13G
| Lind Global Fund II LP reports a 6.2% stake in Palisade Bio, Inc. |
| 02/14/2022 |
SC 13G
| Altium Capital Management LP reports a 10% stake in Palisade Bio, Inc. |
| 05/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/29/2020 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5% stake in Seneca Biopharma, Inc. |
| 02/12/2020 |
SC 13G
| RENAISSANCE TECHNOLOGIES LLC reports a 6.7% stake in SENECA BIOPHARMA, INC. |
| 08/09/2019 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Neuralstem, Inc. |
| 11/05/2018 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5.7% stake in Neuralstem, Inc. |
| 10/26/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2018 |
SC 13G
| Hudson Bay Capital Management LP reports a 5.8% stake in Neuralstem, Inc. |
| 08/07/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/22/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/16/2012 |
SC 13G
| RUNNELS G TYLER reports a 6% stake in Neuralstem, Inc. |
|
|